Meet Jovan Hutton Pulitzer and some of his award-winning inventions
Get to know Jovan Hutton Pulitzer and some of his inventions: Jovan Hutton Pulitzer, Award-Winning Inventor, is a highly active technology start-up founder, best known for creating and patenting :CRQ (See Our Cue – Q Code Platform for Scan Commerce and Scan to Connect) has founded companies have included seed investment rounds ranging from $1.6m to over $250m with companies supported and funded by Dreamit Ventures, and Microventures to name a few lead investors.
Pulitzer’s patents have been licensed to more than 330 companies, ranging from early-stage firms to Fortune 100 Industry Leaders such as eBay, IBM, AOL, Cisco, Google, Walgreen Co, TiVo Brocade Communications Systems, Inc.; Crate & Barrel Holdings, Inc.; F5 Networks, Inc.; Quick Logic Corporation; Rackspace Hosting, Inc.; Taiwan Semiconductor Manufacturing Company, Ltd.; Zynga Inc., Advanced Micro Devices, Inc., Avaya Inc., Ericsson AB, MobiTV, Inc., Nikon Corporation, Pioneer Corporation, NEC Corporation, Hitachi, Ltd., Novell, Inc.; Leap Wireless International Inc.; Barnes & Noble, Inc., Broadcom Corporation, Qualcomm Incorporated, Intel Corporation, Sony Corporation, HTC Corporation, LG Electronics Inc., Nokia Corporation, Samsung Electronics Co., Ltd., Best Buy Co, Inc., Fujitsu Limited, Intuit Inc., and Juniper Networks, Inc.
Additionally, Jovan Hutton Pulitzer is an Author of over 200 individual history and treasure legend books is a well-known media personality who has appeared on Fox TV, ABC, NBC, CBS, PBS History Channel, and other networks. Pulitzer is also known as an Explorer, Publisher and Inventor. Pulitzer has several hundred patents domestically and patents in 189 countries globally. His Scan-To-Connect and Scan Commerce Patents are now licensed to all global mobile device manufacturers who have more than 11 billion devices utilizing his vast patent portfolio(s). Discover extra information at Who is Jovan Hutton Pulitzer?
Pulitzer and his technology won the 2001 Smithsonian Laureate Medal for “Most Likely to Change Society”. As part of winning the Smithsonian Award, the Pulitzer Patents and history of their development are part of Case Studies in 140 Universities and Museums, such as Brown University, Duke University, Yale University, Princeton University, Harvard University, and Helsinki University of Technology.
Pulitzer’s Scan Commerce and Scan-to-Connect patent portfolio (LV Partners) was bought by RPX Corporation. RPX Corporation (NASDAQ: RPXC) is a spin-off of Intellectual Ventures. RPX is a defensive patent aggregator that buys patents or patent licenses, and then turns around and licenses these patents or patent rights to their member clients, such as Apple, Google, Samsung, HTC, Facebook, Fujifilm, Microsoft, RIM, Adobe, Amazon, Huawei Technologies, and Shutterfly. In December 2014, RPX purchased 4000patents from Rockstar Consortium through its RPX Clearinghouse subsidiary for $900 million.
Pulitzer’s TV Creation and Syndicated Series won the Platinum WorldFest Award in 2001 for TV. Worldfest is the event that discovered Steven Spielberg, George Lucas, Ang Lee, John Lee Hancock, Randall Kleiser, Ridley Scott, Robert Rodriguez, Robert Townsend, The Coen Brothers, Spike Lee, Oliver Stone, and David Lynch with their very first awards. WorldFest has emerged as the oldest film festival management in the world, with the same continuous director for more than 50 consecutive years.
To know you are pregnant but to suspect you have been exposed to the Zika Virus and then have to wait over 12 weeks of a 40 weeks pregnancy for results is unacceptable. We had to do something about it and fast! The end result is a new patented line of pregnancy tests that will not only be able to detect your pregnancy sooner but will also be able to detect if you have been exposed to the dreaded Zika Virus, enabling women to make better-informed health care decisions. The United States Patent and Trademark office list the base patents as Arbovirus indicative birth defect risk test and a Pregnancy test to assess disease risk.